Dr. Bernd Muehlenweg

Dr. Bernd Muehlenweg has more than 2 decades of experience in senior positions focusing on business and corporate development and alliance management in the pharmaceutical and biotechnology industries. He has been involved in establishing a broad bandwidth of collaborations to develop and commercialize assets from early-stage to late-stage clinical development. Dr. Muehlenweg also founded Panoptes Pharma GmbH, a biotechnology start-up that was acquired by a Nasdaq-listed company. He currently serves as Senior Vice President of Global Business Development at Evotec. Before this, Dr. Muehlenweg held the position of Chief Business Officer, Member of the Executive Board, at Nanobiotix, a French clinical-stage oncology company. Building sustainable and durable partnerships to advance innovative approaches into approved medications has been driving him throughout his career.